Humana Inc (HUM)

HUM (NYSE:Health Services) EQUITY
$236.11
neg -0.89
-0.38%
Today's Range: 235.42 - 238.08 | HUM Avg Daily Volume: 1,486,600
Last Update: 06/23/17 - 1:30 PM EDT
Volume: 340,676
YTD Performance: 16.16%
Open: $237.11
Previous Close: $237.00
52 Week Range: $150.00 - $241.33
Oustanding Shares: 144,314,925
Market Cap: 34,088,628,434
6-Month Chart
TheStreet Ratings Grade for HUM
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 2 1 1 1
Hold 6 6 6 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.84 1.87 1.87 1.69
Latest Dividend: 0.40
Latest Dividend Yield: 0.68%
Dividend Ex-Date: 06/28/17
Price Earnings Ratio: 57.47
Price Earnings Comparisons:
HUM Sector Avg. S&P 500
57.47 58.00 30.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.10% 26.29% 86.39%
GROWTH 12 Mo 3 Yr CAGR
Revenue 11.90 0.00 0.00
Net Income -51.90 -0.50 -0.21
EPS -51.80 -0.50 -0.19
Earnings for HUM:
EBITDA 0.00B
Revenue 54.38B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $3.05 $3.24 $11.13 $12.17
Number of Analysts 11 10 10 11
High Estimate $3.29 $3.34 $11.23 $12.75
Low Estimate $2.85 $3.05 $11.00 $11.50
Prior Year $2.30 $3.18 $9.57 $11.13
Growth Rate (Year over Year) 32.81% 1.92% 16.33% 9.31%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
We really want to shake out the weak hands here.
It's a wonder to me how split this market really is.
Clearing $220 will set the stage for insurer's move.
Bearish
Apr 21, 2017 | 9:02 AM EDT
Humana was downgraded at Jefferies to "Hold" from "Buy" to with a $221 price target.
Their overseas business has been carrying them.
This reversal has been incredible to watch.
With a strong chart and indicators, shares are poised to make further new highs.

Health Care Putting in a Base Real Money Pro($)

Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (XLV) (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. Last year more than $18 billion was redeemed out of the healthcare ETFs, according to Morningstar. However there are some technical signposts that the two-year period of underperformance might be ending, as a basing seems likely. Look at the chart and note the recent higher high.
There are too many zero-sum games being portrayed as win-wins.
Bull market number one, perhaps of all time: the financials.

Columnist Conversations

Impinj ( $PI) is still forming a bull flag. Holding up just fine, and 27% of float is short. This is a powe...
stellar numbers and the stock continues to attract buyers, it's now in the fat tail and this could go for a fe...
General Electric's outgoing CEO Jeff Immelt had some choice things to say at an event in NYC on Thursday ...
our chart of the week worked out nicely! we'll bank this big winner and roll up SOLD BIIB AUG 270 CALL AT...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.